win 52035 has been researched along with win 53338 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diana, GD; Dutko, FJ; Kowalczyk, P; Oglesby, RC; Pevear, DC; Treasurywala, AM | 1 |
Bailey, TR; Diana, GD; Dutko, FJ; Oglesby, RC; Pevear, DC; Treasurywala, AM | 1 |
Akullian, V; Carabateas, PM; Cutcliffe, D; Diana, GD; Maliski, EG; Mallamo, JP; McKinlay, MA; Michalec, SJ; Oglesby, RC; Otto, MJ | 1 |
Abraham, U; Klebe, G | 1 |
Cedergren, R; Leclerc, F | 1 |
5 other study(ies) available for win 52035 and win 53338
Article | Year |
---|---|
CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.
Topics: Antiviral Agents; Binding Sites; Humans; Isoxazoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Rhinovirus; Stereoisomerism; Structure-Activity Relationship; X-Ray Diffraction | 1992 |
A model for compounds active against human rhinovirus-14 based on X-ray crystallography data.
Topics: Antiviral Agents; Binding Sites; Capsid; Isoxazoles; Microbial Sensitivity Tests; Models, Molecular; Oxazoles; Rhinovirus; Structure-Activity Relationship; X-Ray Diffraction | 1990 |
Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating.
Topics: Antiviral Agents; Humans; Indicators and Reagents; Isoxazoles; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Oxazoles; Rhinovirus; Species Specificity; Structure-Activity Relationship | 1987 |
On the prediction of binding properties of drug molecules by comparative molecular field analysis.
Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Crystallography; Drug Design; Humans; Molecular Conformation; Molecular Sequence Data; Reference Standards; Renin; Rhinovirus; Thermolysin | 1993 |
Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antiviral Agents; Binding Sites; Computer Simulation; Crystallography, X-Ray; Gene Products, rev; Humans; Ligands; Macromolecular Substances; Models, Chemical; Models, Molecular; Nucleic Acid Conformation; Protein Conformation; Rhinovirus; RNA, Viral; Structure-Activity Relationship | 1998 |